COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 1016: Articles 10151-10160  | Next

Durability of Response to a Third BNT162b2 Vaccine in Adults >=60 Years
Eliakim Raz, N., Stemmer, A., Leibovici-Weissman, Y., Ness, A., Awwad, M., Ghantous, N., Erez, N., Bareket-Samish, A., Levy-Barda, A., Ben-Zvi, H., Moskovits, N., Bar-Haim, E., Stemmer, S.
10.1101/2021.12.25.21268336 — Posted: 2021-12-27
BNT162b2 boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Behrens, G. M., Barros-Martins, J., Cossmann, A., Morillas Ramos, G., Stankov, M. V., Odak, I., Dopfer-Jablonka, A., Hetzel, L., Koehler, M., Patzer, G., Binz, C., Ritter, C., Friedrichsen, M., Schultze-Florey, C. R., Inga, R., Willenzon, S., Bubke, A., Rispenpart, J., Janssen, A., Ssebyatika, G., Bernhardt, G., Hoffmann, M. R., Poehlmann, S., Krey, T., Bosnjak, B., Hammerschmidt, S. I., Foerster, R.
10.1101/2021.12.25.21268392 — Posted: 2021-12-27
NATIONAL SCALE REAL-TIME SURVEILLANCE OF SARS-COV-2 VARIANTS DYNAMICS BY WASTEWATER MONITORING IN ISRAEL
Bar-Or, I., Indenbaum, V., Weil, M., Elul, M., Levi, N., Aguvaev, I., Cohen, Z., Levy, V., Azar, R., Mannasse, B., Shirazi, R., Buchris, E., Zuckerman, N. S., Sela Brown, A., Sofer, D., Mor, O., Mendelson, E., Erster, O.
10.1101/2021.12.26.21268420 — Posted: 2021-12-27
SARS-CoV-2 Omicron VOC Transmission in Danish Households
Lyngse, F. P., Mortensen, L. H., Denwood, M. J., Christiansen, L. E., Moller, C. H., Skov, R. L., Spiess, K., Fomsgaard, A., Lassauniere, R., Rasmussen, M., Stegger, M., Nielsen, C., Sieber, R. N., Cohen, A. S., Moller, F. T., Overvad, M., Molbak, K., Krause, T. G., Kirkeby, C. T.
10.1101/2021.12.27.21268278 — Posted: 2021-12-27 Discussion: Onsite
Post COVID-19 1st Dose Vaccination Common Symptoms among SE Asia College Students
Wibowo, A., Yostyadiananda, N. O., Gunawan, G. R.
10.1101/2021.12.21.21268173 — Posted: 2021-12-27
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant
Hingankar, N., Deshpande, S., Das, P., Rizvi, Z. A., Burns, A., Barman, S., Zhao, F., Ansari, M. Y., Mukherjee, S., Torres, J. L., Chattopadhyay, S., Mehdi, F., Sutar, J., Rathore, D. K., Pargai, K., Singh, J., Sonar, S., Jakhar, K., Bhattacharyya, S., Mani, S., Singh, S., Dandotiya, J., Kshetrapal, P., Thiruvengadam, R., Batra, G., Medigeshi, G. R., Ward, A., Bhatnagar, S., Awasthi, A., Sok, D., Bhattacharya, J.
10.1101/2021.12.25.474152 — Posted: 2021-12-27
Assessing Immunity by Quantitative Measurement of SARS-CoV-2 IgG Antibodies in Fingerstick Samples
Garza, J. T., Quick, J., Chatterjee, D., Garr, R. P., Varadhachary, A., Linbeck, L.
10.1101/2021.12.21.21268075 — Posted: 2021-12-27
Utilization of a SARS-CoV-2 Variant Assay for the Rapid Differentiation of Omicron and Delta
Barasch, N. J., Iqbal, J., Coombs, M., Kazi, S., Wang-Rodriguez, J., Holodniy, M., Gelman, M.
10.1101/2021.12.22.21268195 — Posted: 2021-12-27
SIR model for assessing the impact of the advent of Omicron and mitigating measures on infection pressure and hospitalization needs
van wees, j.-d., van der Kuip, M., Osinga, S., Keijser, B., Van Westerloo, D., Hanegraaf, M., Pluymaekers, M., Leeuwenburgh, O., Brunner, L., Tutu-van Furth, M.
10.1101/2021.12.25.21268394 — Posted: 2021-12-27
Temporal trends in hospitalizations and 30-day mortality in older patients during the COVID pandemic from March 2020 to July 2021
Garcia-Ptacek, S., Xu, H., Annetorp, M., Back Jerlardtz, V., Cederholm, T., Engstrom, M., Kivipelto, M., Lundberg, L. G., Metzner, C., Olsson, M., Skogo Nyvang, J., Suhl Oberg, C., Akesson, E., Religa, D., Eriksdotter, M.
10.1101/2021.12.22.21268237 — Posted: 2021-12-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).